{
    "domain": "alchemer.eu",
    "owner": {},
    "source": [
        "DuckDuckGo-US"
    ],
    "prevalence": 0.0000139,
    "sites": 2,
    "subdomains": [
        "survey"
    ],
    "cnames": [],
    "fingerprinting": 0,
    "resources": [
        {
            "rule": "alchemer\\.eu\\/s3\\/90325279\\/ADS-Poll-39-Change-in-M-A-intensity-in-2021",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "dc8eaf561ffab82d20d5aab2b2c312bd7dfee793a5f9033556d0df683e561af7"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90366963\\/All-Sites-ESG-Poll-1-Q3-2021-Main-driver-for-adoption-of-ESG-practices",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "5f9bc6e47580b6db2e0b288dad194273a6af7a8b07b100bb7492152fd2af39db"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358855\\/Wearables-Poll-2-Wearables-Functionalities",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "ffa42ae4d55dcb4ae3dbaa02a7b800aa7650cc24f88820754c7fa0e3199bfcf3"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90366967\\/All-Sites-ESG-Poll-3-Q3-2021-Proxy-ESG-program-for-business-management",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "eaf68115b4ae9d8d6e7f0cd6d0d1e7c27607fc9af140176b8e97d0fd7f3b2004"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90329002\\/ADS-Poll-43-Impact-of-lithium-ion-batteries-on-submarine-market",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "a83ea5c43df78ef6c36b72f5ec1ba4d6d2fcefa6366deefa0aba41fd3135624a"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90337851\\/T-T-Poll-18-Preferred-length-of-stay-for-leisure-trip",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "f6119b07532312d9dcab4106b103ead5cbc71bfc1890fb7a35004804e18641cf"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358868\\/Streaming-Services-Poll-3-Streaming-Services-Challenges-Concerns",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "3d3d30aa55c94c54bdf77772ede00d1a16d505af7490e48621af525490ff3708"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90366972\\/All-Sites-ESG-Poll-6-Q3-2021-Themes-likely-to-impact-the-business-in-next-12-months",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "36c13f2f4efc51c44b5bafabe2e80f118ea87604e000578ee473e43e92210a63"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358866\\/Streaming-Services-Poll-2-Streaming-Services-Drivers",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "004df3a6ff3418987dd9dc0e5c8bd13894a4c958de93aa14bbbbd36e80ba782a"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358861\\/Wearables-Poll-4-Wearables-Spend-Analysis",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "a72aa563d374406a883375d50319f5fc8f2176f3d6d5b2aa6387acc98266dd16"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90366975\\/All-Sites-ESG-Poll-9-Q3-2021-Studying-ESG-issues-before-investing-in-a-company",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "675387abc0f8893f8cf0012723bca2a84029085bc000c5e5a832e6b5aeebb628"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90329022\\/ADS-Poll-46-Impact-of-European-budget-deficits-on-joint-programs",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "3f2ea2955a8e42ba803b875de53d79c9a9ce196730e16c97b1169a0a42174cb7"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90330010\\/All-Sites-WFH-poll-2-Q1-2021",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "e388ab34b59b4bcd6e5b63bdfce5afa9935b600ec05ed2b41d0b0d9765650cfd"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358857\\/Wearables-Poll-3-Wearables-Challenges-Concerns",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "25cb13cc4446c92d8097c7395376f1b57c9b3832b5398fb35d35c649980d0dd4"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90359219\\/ADS-Poll-48-Integration-of-EVs-into-Armed-forces",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "7648319407bd4af36db528f6c54ce710576b81f27c8d43a64edce4d2a69a90a7"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358850\\/Wearables-Poll-01-Wearables-Awareness-Usage",
            "cookies": 0.00000694,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "0e0c17581c7c75a2cd641c57c06ecce93d7364803de8fee830d7c39871aad93c"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358869\\/Streaming-Services-Poll-4-Streaming-Services-Spend-Analysis",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "51177a8433c6498fc9bbe44177611c9800a169c89b4dd050c43ed93c060f2b7b"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90358862\\/Streaming-Services-Poll-01-Streaming-Services-Awareness-Usage",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "6de74229c0dfe982fe5144333305abf1197598b76b50abc351922f01c41d9e5b"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90359220\\/ADS-Poll-49-Impact-area-of-3D-printing",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "ae012cb056e26745a7bf06b7e818cfb06e999b1a2d861500c6a013f2ec38945e"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "army-technology.com",
                "www.army-technology.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90347071\\/All-Sites-G2-Poll-7-The-Office-of-the-Future",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "05a5e11eb60c0dd3f42bc302916536866b7c30d6d78e1ab45456fb1c04af7b8d"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344129\\/CTA-Poll-20-Relevance-of-data-governance-or-privacy",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "5fa5638b382a94a64ae32dc70c106d9f67f449465db238b3fd4f83aa3e7decf2"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90347068\\/All-Sites-G2-Poll-6-The-Office-of-the-Future",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "2099fb4f1ceb01e8d2be0365e52c993b43d894315a9d0575ebf2d992fa1df987"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344124\\/CTA-Poll-15-Addressing-clinical-trial-disruptions",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "6913da58245258dcb9f6e63ad9d149a1ae76893ae2993e92c53c363941201d87"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90347067\\/All-Sites-G2-Poll-5-The-Office-of-the-Future",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "327c3cfa2510a77a711ee2bdb444217a773ca0a47cb28716be7b3520f1707435"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344131\\/CTA-Poll-21-Evaluation-of-data-management-solutions",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "afddec0d890c362484c21ffe220243ab71454005e5f17d4beea8b1e136fd0fb8"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350244\\/Pharma-Poll-42-Pharma-value-best-supported-by-Remote-Patient-Monitoring",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "3a32dda2269be6af1ce899a6e10dbdff8484dcc989dbb90e557ab1f0d319eac4"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344118\\/CTA-Poll-12-Usage-of-decentralized-virtual-clinical-trials",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "d76ed15305de3875fee73796fb9609e6690068abe72a48f0d67c47ad89eb18b2"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344126\\/CTA-Poll-17-Cost-of-decentralized-virtual-clinical-trials-vs-traditional-trials",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "b2c5d53437966c932245b0861ba4a04b72bf264821e508b85c558f0e4569379c"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350256\\/Pharma-Poll-46-Most-important-consideration-to-ensure-success-of-virtual-clinical-trials",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "a370afe3f855f37094e71fb53fc263761c104ffccba4899933a60bac6b7cb890"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344125\\/CTA-Poll-16-Primary-reason-for-using-the-virtual-trial-model",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "c9606440688af9fad3ea0963187217511968b9662a7636b37d8270ed6a1b92ad"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344119\\/CTA-Poll-13-Timeline-of-using-decentralized-virtual-clinical-trials",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "4432ee92b5b64704cc90f477ab2b90270f3c799778446723858b25a27a6cc7bd"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344123\\/CTA-Poll-14-Impact-of-COVID-19-pandemic-on-clinical-trials",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "66de2cb7556a84a98dafb29f0d65f2314ff423e4057da78d9939a44d35b71fc7"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344115\\/CTA-Poll-11-Decentralized-virtual-clinical-trials-due-to-Covid-19",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "d2ec3926febde6dcb711513238fd8d2dd54d529f8be49df2a1500e8ff7a4b4ff"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344128\\/CTA-Poll-19-Mode-of-handling-data-collection",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "99476a1922469d3234b1152bd5ffdc93069c821f8923f9e158fa256de6b4d15b"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350246\\/Pharma-Poll-43-Main-benefit-of-integrating-digital-tools-into-trials",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "6c25bb1440f7bf8e36af3e7cafda7a483434c16418ded64d1184a9a23d6b84ad"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90344127\\/CTA-Poll-18-Risk-of-deviations-of-decentralized-virtual-clinical-trials-vs-traditional-trial-research",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "5de6e937aaef4b53c72edb79929dd2193e3523b38b7bcee2abd103546845905d"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350250\\/Pharma-Poll-44-Regulatory-barrier-towards-adopting-software-enabled-practices",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "175c1beaf77649bf9360abb0a9b1c299d2a96d3d82dcd74037a6dc379095dcb2"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        },
        {
            "rule": "alchemer\\.eu\\/s3\\/90350253\\/Pharma-Poll-45-Main-design-challenge-of-RPM-technologies",
            "cookies": 0.0000139,
            "fingerprinting": 0,
            "subdomains": [
                "survey"
            ],
            "apis": {},
            "sites": 2,
            "prevalence": 0.0000139,
            "cnames": [],
            "responseHashes": [
                "0bccdd0552b2b7d00054b143bc4a75c157597edef6bace584415f56d446354db"
            ],
            "type": "Document",
            "firstPartyCookies": {},
            "firstPartyCookiesSent": {},
            "exampleSites": [
                "clinicaltrialsarena.com",
                "www.clinicaltrialsarena.com"
            ]
        }
    ],
    "categories": [],
    "performance": {},
    "cookies": 0.0000139,
    "types": {
        "Document": 76
    },
    "nameservers": [
        "ns-898.awsdns-48.net",
        "ns-1127.awsdns-12.org",
        "ns-1912.awsdns-47.co.uk",
        "ns-440.awsdns-55.com"
    ]
}